Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.
Ann Oncol
; 5(3): 283-5, 1994 Mar.
Article
in En
| MEDLINE
| ID: mdl-8186176
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Small Cell
/
Deoxycytidine
/
Lung Neoplasms
/
Antimetabolites, Antineoplastic
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
1994
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido